VR1's Unattributed - III Round

VR1 raised a round of funding on May 13, 2014.

VR1 specializes in the development and marketing of medicines aimed at reducing the pain and side effects associated with migraines and severe headaches. Ausanil is formulated to rapidly provide relie…

Articles about VR1's Unattributed - III Round: